Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Anticandidal Property of Saccharomyces Boulardii on Very Low Birth Weight Infants Clinical Trial

Status Recruiting

Clinical Trial Summary

Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic S boulardii in reducing the candida colonization and infection in very low birth weight infants.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Anticandidal Property of Saccharomyces Boulardii on Very Low Birth Weight Infants
• Birth Weight

• NCT number: NCT01411748
• Study type: Interventional
• Source: Zekai Tahir Burak Women's Health Research and Education Hospital
• Status: Recruiting
• Phase: Phase 4
• Start date: July 2011
• Completion date: December 2011